1. Agid, Y., Quinn, N., Pollack, P., Illas, A., Destee, A., Signoret, J. L., Lhermitte, F.: The treatment of parkinson's disease with dopaminergic agonists in combination with domperidone. In: Apomorphine and Other Dopaminomimetics (Corsini, G. U., Gessa, G. L., eds.), Vol.2, pp. 107?115. New York: Raven Press. 1981.
2. Agnoli, A., Baldassera, M., Del Roscio, S., Palesse, N., Ruggieri, S.: Piribedil and parkinson's disease: protection of peripheral side-effects by domperidone. In: Apomorphine and other Dopaminomimetics (Corsini, G. U., Gessa, G. L., eds.), Vol.2, pp. 117?122. New York: Raven Press. 1981.
3. Brouillard, J. F., Donatsch, P.: Simultaneous determination of CU 32-085 and its main metabolites in plasma by high performance liquid chromatography and fluorescence detection. J. Chromatogr. (in press, 1984).
4. Calne, D. B., Plotkin, C., Williams, A. C., Nutt, J. G., Neophytides, A., Teychenne, P. F.: Long-term treatment of parkinsonism with bromocriptine. Lanceti, 735?738 (1978).
5. Enz, A.: Biphasic influence of a 8-?-amino-ergoline, CU 32-085, on striatal dopamine synthesis and turnoverin vivo in the rat. Life Sci.29, 2227?2234 (1981).